Possible involvement of cyclic AMP-dependent protein kinase in p,p'-DDT-induced changes in hepatic metabolism

DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.

Oncogene·2016

The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.

Oncogene·2011

P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.

Oncogene·2011

Characterization and role of NUMB in the human extravillous trophopblast.

Placenta·2011

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.

Oncogene·2009

Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion.

Placenta·2009

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

Biochemical pharmacology·2026

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Biochemical pharmacology·2026

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Biochemical pharmacology·2026

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Biochemical pharmacology·2026

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

Biochemical pharmacology·2026

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

Biochemical pharmacology·2026

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

Asian journal of andrology·2026

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

Blood cancer discovery·2026

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Cancer research·2026

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

Expert opinion on investigational drugs·2026

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Future oncology (London, England)·2026

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

The oncologist·2026

Related Experiment Videos

Possible involvement of cyclic AMP-dependent protein kinase in p,p'-DDT-induced changes in hepatic metabolism

Related Concept Videos

DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.

The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.

P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.

Characterization and role of NUMB in the human extravillous trophopblast.

Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.

Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion.

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

Onvansertib-mediated PLK1 inhibition impairs spermatogenesis in the murine testis.

RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Emerging therapeutic strategies and clinical development of investigational agents for conventional chondrosarcoma.

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Real-world treatment patterns in men with metastatic hormone-sensitive prostate cancer in Europe and Asia between 2020 and 2024.

Related Experiment Videos

Possible involvement of cyclic AMP-dependent protein kinase in p,p'-DDT-induced changes in hepatic metabolism

Related Concept Videos

Related Articles